ConductScience.org, home

Paper39435002

Identification of new leads against ubiquitin specific protease-7 (USP7): a step towards the potential treatment of cancers.

Javaid S and 6 others. RSC Adv, 2024. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Identification of new leads against ubiquitin specific protease-7 (USP7): a step towards the potential treatment of cancers. Papers, record 39435002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39435002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of new leads against ubiquitin specific protease-7 (USP7): a step towards the potential treatment of cancers.
PubMed
Journal
RSC Adv
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.95, provisional
iCite
Revised in PubMed
2024-10-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Javaid SSumairahttps://orcid.org/0000-0002-6422-3022
2Zadi SSeema
3Awais MMuhammad
4Wahab ATAtia-Tul
5Zafar HHumaira
6Maslennikov IInnokentiy
7Choudhary MIM Iqbal

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112507430Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.Cell2002https://conductscience.org/library/papers/12507430PubMed
229045389Molecular basis of USP7 inhibition by selective small-molecule inhibitors.Nature2017https://conductscience.org/library/papers/29045389PubMed
324598911A 2.2 Å resolution structure of the USP7 catalytic domain in a new space group elaborates upon structural rearrangements resulting from ubiquitin binding.Acta Crystallogr F Struct Biol Commun2014https://conductscience.org/library/papers/24598911PubMed
438468948Repurposing of US-FDA-approved drugs as negative modulators of ubiquitin specific protease-7 (USP7).Heliyon2024https://conductscience.org/library/papers/38468948PubMed
516898897The safety of hydroquinone.J Eur Acad Dermatol Venereol2006https://conductscience.org/library/papers/16898897PubMed
631986186Thymidine phosphorylase and prostrate cancer cell proliferation inhibitory activities of synthetic 4-hydroxybenzohydrazides: In vitro, kinetic, and in silico studies.PLoS One2020https://conductscience.org/library/papers/31986186PubMed
728498721Mechanisms of Deubiquitinase Specificity and Regulation.Annu Rev Biochem2017https://conductscience.org/library/papers/28498721PubMed
817853878The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability.Nat Protoc2007https://conductscience.org/library/papers/17853878PubMed
99581515Cytotoxic activity of labdane type diterpenes against human leukemic cell lines in vitro.Planta Med1998https://conductscience.org/library/papers/9581515PubMed
1021468693The multifaceted roles of USP7: new therapeutic opportunities.Cell Biochem Biophys2011https://conductscience.org/library/papers/21468693PubMed
1136834633Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders.Int J Mol Sci2023https://conductscience.org/library/papers/36834633PubMed
1235852517Targeting the deubiquitinase USP7 for degradation with PROTACs.Chem Commun (Camb)2022https://conductscience.org/library/papers/35852517PubMed
1325972356Deubiquitinases in cancer.Oncotarget2015https://conductscience.org/library/papers/25972356PubMed
1411741787Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.Bioorg Med Chem2002https://conductscience.org/library/papers/11741787PubMed
1536186590Highlights in USP7 inhibitors for cancer treatment.Front Chem2022https://conductscience.org/library/papers/36186590PubMed
1632300595Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?Front Cell Dev Biol2020https://conductscience.org/library/papers/32300595PubMed
1719434839Identifying and characterizing binding sites and assessing druggability.J Chem Inf Model2009https://conductscience.org/library/papers/19434839PubMed
1835209141Synthesis, Characterization, Biological Evaluation and DNA Interaction Studies of 4-Aminophenol Derivatives: Theoretical and Experimental Approach.Molecules2022https://conductscience.org/library/papers/35209141PubMed
1937245535Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.Biochem Pharmacol2023https://conductscience.org/library/papers/37245535PubMed
2034474304Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy.Bioorg Chem2021https://conductscience.org/library/papers/34474304PubMed

See all 39 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42353625Screening of Natural Product-Derived USP7 Inhibitors for Cancer Therapy via Integrated Machine Learning and Molecular Simulations.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42353625PubMed
41157055USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and Tumorigenesis.Molecules2025https://conductscience.org/library/papers/41157055PubMed
40472738The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression.Neoplasia2025https://conductscience.org/library/papers/40472738PubMed
40165995Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSP.Drug Des Devel Ther2025https://conductscience.org/library/papers/40165995PubMed
40001543Ubiquitin-Specific Protease Inhibitors for Cancer Therapy: Recent Advances and Future Prospects.Biomolecules2025https://conductscience.org/library/papers/40001543PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
USP77874PubTator's text mininghttps://conductscience.org/library/genes/7874NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39435002

GET https://conductscience.org/api/papers/v1/39435002/references?page=2